Page results
-
Information about Magnetic Resonance Imaging (MRI) scans at UCLH.
-
Patient information for women who have chosen to have surgical management under general anaesthetic following a diagnosis of a miscarriage.
-
Dr Lynch is a consultant neurologist at the National Hospital for Neurology and Neurosurgery. He sees patients with all types of neurological disease in his general neurology clinics, and he has a particular interest in patients with inherited disorders of white matter, also called leukodystrophies
-
School training dates for September 2020 including an Eventbrite link
-
This page is for parents and carers of children with sickle cell disease. It explains what happens during a Transcranial Doppler Scan.
-
Info about our regular, online origami club for people under the care of UCLH for cancer or a blood condition
-
This patient information is intended to help patients suffering form long COVID to manage and understand their headaches.
-
This information page has been written to help answer some of the questions you may have about brain metastases, and their treatment with this specialised radiotherapy technique.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using hybrid closed loop (HCL) systems.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
File results
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311